Form 8-K - Current report:
SEC Accession No. 0001213900-24-077934
Filing Date
2024-09-12
Accepted
2024-09-12 08:47:41
Documents
22
Period of Report
2024-09-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0214325-8k_xencor.htm   iXBRL 8-K 37677
2 UNDERWRITING AGREEMENT, DATED SEPTEMBER 10, 2024, BY AND AMONG XENCOR, INC. AND ea021432501ex1-1_xencor.htm EX-1.1 235970
3 FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK ea021432501ex4-1_xencor.htm EX-4.1 80046
4 OPINION OF PAUL HASTINGS LLP ea021432501ex5-1_xencor.htm EX-5.1 9960
5 PRESS RELEASE, DATED SEPTEMBER 10, 2024 ea021432501ex99-1_xencor.htm EX-99.1 8271
6 PRESS RELEASE, DATED SEPTEMBER 11, 2024 ea021432501ex99-2_xencor.htm EX-99.2 8144
7 GRAPHIC ex5-1_001.jpg GRAPHIC 9726
8 GRAPHIC ex5-1_002.jpg GRAPHIC 3581
9 GRAPHIC ex99-1_001.jpg GRAPHIC 19422
10 GRAPHIC ex99-2_001.jpg GRAPHIC 19422
  Complete submission text file 0001213900-24-077934.txt   721088

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE xncr-20240910.xsd EX-101.SCH 3009
12 XBRL LABEL FILE xncr-20240910_lab.xml EX-101.LAB 34240
13 XBRL PRESENTATION FILE xncr-20240910_pre.xml EX-101.PRE 22355
24 EXTRACTED XBRL INSTANCE DOCUMENT ea0214325-8k_xencor_htm.xml XML 3568
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36182 | Film No.: 241293988
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)